TRPC channels blockade abolishes endotoxemic cardiac dysfunction by hampering intracellular inflammation and Ca2+

Na Tang1,2, Wen Tian3,4, Guang-Yuan Ma1,2

  • 1Department of Pharmacy, School of Chemistry & Pharmacy, Northwest A&F University, Yangling, Shaanxi, China.

Nature Communications
|December 2, 2022
PubMed

Insights

Targeting TRPC1 and TRPC6 channels, crucial for calcium regulation, can treat septic cardiac dysfunction. Blocking these channels prevents calcium leaks and inflammation, improving heart function and survival in sepsis models.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Immunology

Background:

  • Sepsis-induced cardiac dysfunction involves intracellular calcium dysregulation.
  • Conventional calcium regulatory pathways do not fully resolve this condition.

Purpose of the Study:

  • To investigate the role of Transient Receptor Potential Canonical (TRPC) channels TRPC1 and TRPC6 in septic cardiac dysfunction.
  • To explore TRPC1/TRPC6 as therapeutic targets for sepsis-related heart failure.

Main Methods:

  • Utilized knockout mouse models for Trpc1 and Trpc6.
  • Assessed lipopolysaccharide (LPS)-induced cardiac dysfunction and survival rates.
  • Investigated calcium (Ca2+) release from the endoplasmic reticulum in cardiomyocytes and macrophages.
  • Examined the interaction between calmodulin, TRPC channels, and Toll-like receptor 4 (TLR4).
  • Tested a chemical inhibitor targeting the TRPC C-terminal CaM/IP3R binding domain.

Main Results:

  • Trpc1 or Trpc6 knockout significantly ameliorated LPS-induced heart failure and prolonged survival in mice.
  • Knockout of Trpc1 or Trpc6 inhibited LPS-triggered Ca2+ release from the endoplasmic reticulum.
  • Calmodulin uncoupling from TRPC channels in Trpc1/Trpc6 deficient cells blocked the TLR4-mediated inflammation cascade.
  • Chemical inhibition of the TRPC C-terminal CaM/IP3R binding domain demonstrated cardioprotective effects.

Conclusions:

  • TRPC1 and TRPC6 channels are critical mediators of calcium dysregulation and inflammation in septic cardiac dysfunction.
  • Targeting TRPC1/TRPC6 channels offers a novel therapeutic strategy for endotoxemia and sepsis-related heart failure.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
657
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
617
Feedback Regulation of Calcium Concentration01:27

Feedback Regulation of Calcium Concentration

Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
3.4K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
4.7K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.2K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
18